// App-Quantinova.ai

4131 : Blocking endogenous TBX2 abrogates prostate cancer bone metastasis through WNT signaling

Researchers

Presenter

  • Srinivas Nandana

Principal Investigators

  • Manisha Tripathi

  • Peng Duan

  • Gina Chu

  • Haiyen E. Zhau

  • Robert J. Matusik

  • Leland W.K. Chung

Medical Centers

  • Cedars-Sinai Medical Center, Los Angeles, CA

  • Vanderbilt University, Nashville, TN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

  • Urology

Disease

  • Bone metastases

  • Prostate cancer

  • Solid malignancies

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • T-box 2

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved